Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nunes

Showing results (211-220 of 248) with videos related to

Pageof 25
Sort By:
Journal of Medicinal Chemistry|February 19, 2008
Structure-based design of novel 2-amino-6-phenyl-pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activityMatthew W Martin, John Newcomb, Joseph J Nunes, et al.
Nature|November 30, 2007
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetesJill C Milne, Philip D Lambert, Simon Schenk, et al.
Plos One|August 17, 2018
Pre-clinical evaluation of quinoxaline-derived chalcones in tuberculosisThaís C Muradás, Bruno L Abbadi, Anne D Villela, et al.
Journal of Medicinal Chemistry|March 7, 2008
Structure-guided design of aminopyrimidine amides as potent, selective inhibitors of lymphocyte specific kinase: synthesis, structure-activity relationships, and inhibition of in vivo T cell activationErin F DiMauro, John Newcomb, Joseph J Nunes, et al.
Journal of Medicinal Chemistry|August 4, 2006
Novel 2-aminopyrimidine carbamates as potent and orally active inhibitors of Lck: synthesis, SAR, and in vivo antiinflammatory activityMatthew W Martin, John Newcomb, Joseph J Nunes, et al.
Journal of Medicinal Chemistry|September 15, 2006
Discovery of aminoquinazolines as potent, orally bioavailable inhibitors of Lck: synthesis, SAR, and in vivo anti-inflammatory activityErin F DiMauro, John Newcomb, Joseph J Nunes, et al.
Living Reviews in Relativity|November 17, 2017
Cosmology and Fundamental Physics with the Euclid SatelliteLuca Amendola, Stephen Appleby, David Bacon, et al.
Living Reviews in Relativity|April 21, 2018
Cosmology and fundamental physics with the Euclid satelliteLuca Amendola, Stephen Appleby, Anastasios Avgoustidis, et al.
Physical Review Letters|September 26, 2025
Evidence for Longitudinally Polarized W Bosons in the Electroweak Production of Same-Sign W Boson Pairs in Association with Two Jets in pp Collisions at sqrt[s]=13  TeV with the ATLAS DetectorG Aad, E Aakvaag, B Abbott, et al.
Physical Review Letters|August 2, 2024
Statistical Combination of ATLAS Run 2 Searches for Charginos and Neutralinos at the LHCG Aad, B Abbott, K Abeling, et al.
Pageof 25

Showing results (211-220 of 248) with videos related to

Sort By:
Pageof 25
Journal of Medicinal Chemistry|February 19, 2008
Structure-based design of novel 2-amino-6-phenyl-pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activityMatthew W Martin, John Newcomb, Joseph J Nunes, et al.
Nature|November 30, 2007
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetesJill C Milne, Philip D Lambert, Simon Schenk, et al.
Plos One|August 17, 2018
Pre-clinical evaluation of quinoxaline-derived chalcones in tuberculosisThaís C Muradás, Bruno L Abbadi, Anne D Villela, et al.
Journal of Medicinal Chemistry|March 7, 2008
Structure-guided design of aminopyrimidine amides as potent, selective inhibitors of lymphocyte specific kinase: synthesis, structure-activity relationships, and inhibition of in vivo T cell activationErin F DiMauro, John Newcomb, Joseph J Nunes, et al.
Journal of Medicinal Chemistry|August 4, 2006
Novel 2-aminopyrimidine carbamates as potent and orally active inhibitors of Lck: synthesis, SAR, and in vivo antiinflammatory activityMatthew W Martin, John Newcomb, Joseph J Nunes, et al.
Journal of Medicinal Chemistry|September 15, 2006
Discovery of aminoquinazolines as potent, orally bioavailable inhibitors of Lck: synthesis, SAR, and in vivo anti-inflammatory activityErin F DiMauro, John Newcomb, Joseph J Nunes, et al.
Living Reviews in Relativity|November 17, 2017
Cosmology and Fundamental Physics with the Euclid SatelliteLuca Amendola, Stephen Appleby, David Bacon, et al.
Living Reviews in Relativity|April 21, 2018
Cosmology and fundamental physics with the Euclid satelliteLuca Amendola, Stephen Appleby, Anastasios Avgoustidis, et al.
Physical Review Letters|September 26, 2025
Evidence for Longitudinally Polarized W Bosons in the Electroweak Production of Same-Sign W Boson Pairs in Association with Two Jets in pp Collisions at sqrt[s]=13  TeV with the ATLAS DetectorG Aad, E Aakvaag, B Abbott, et al.
Physical Review Letters|August 2, 2024
Statistical Combination of ATLAS Run 2 Searches for Charginos and Neutralinos at the LHCG Aad, B Abbott, K Abeling, et al.
Pageof 25